We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Review · September 11, 2021

Melanoma Risk Associated With Systemic Agents Used to Treat Psoriasis

Journal of Cutaneous Medicine and Surgery

 

Additional Info

Journal of Cutaneous Medicine and Surgery
Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature
J Cutan Med Surg 2021 Aug 15;[EPub Ahead of Print], A Semaka, TG Salopek

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading